English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Regeneron Pharmaceuticals, Inc
Carol Ostrow
| Sep 23, 2017
Study shows Dupixent reduces symptoms of atopic dermatitis
Ruth de Jauregui
| Apr 2, 2017
FDA approves Dupixent for atopic dermatitis
Trending
+
Pharmaceuticals
Patient Daily
| Feb 19, 2025
American Lung Association hosts Fight For Air Climb in Los Angeles
+
Pharmaceuticals
Patient Daily
| Feb 18, 2025
South Florida firefighter aims to defeat lung disease through annual stair climb
+
Pharmaceuticals
Patient Daily
| Feb 18, 2025
Expert tips for managing springtime allergies effectively
+
Regulatory
Patient Daily
| Feb 14, 2025
Spokesperson for Patients Come First: 340B program is ‘one of the most blatant abuses of a governmental program’
